The Second Clinical Medical College, Jinan University, Shenzhen, Shenzhen, China.
Department of Hepatobiliary Surgery, Zhongshan People's Hospital (Zhongshan Hospital Affiliated to Sun Yat-sen University), Zhongshan, China.
Cancer Med. 2024 Feb;13(3):e6933. doi: 10.1002/cam4.6933. Epub 2024 Jan 29.
To investigate the influencing factors affecting the occurrence of microvascular invasion (MVI) and the prognosis of hepatocellular carcinoma (HCC) patients treated with hepatectomy, and to explore how MVI affects prognosis in subgroups with different prognostic factors.
Clinical data of a total of 1633 patients treated surgically for HCC in four treatment centers were included, including 754 patients with MVI. By using the Cox risk regression model and the Mann-Whitney U-test, the common independent influences on prognosis and MVI were made clear. The incidence of MVI in various subgroups was then examined, as well as the relationship between MVI in various subgroups and prognosis.
The Cox risk regression model showed that MVI, Child-Pugh classification, alpha-fetoprotein (AFP), hepatocirrhosis, tumor diameter, lymphocyte-to-monocyte ratio (LMR), and, Barcelona clinic liver cancer (BCLC) grade were independent determinants of overall survival (OS), and MVI, AFP, hepatocirrhosis, tumor diameter, and LMR were influencing determinants for disease-free survival (DFS). The receiver operating characteristic (ROC) curve showed that MVI was most closely associated with patient prognosis compared to other prognostic factors. AFP, hepatocirrhosis, tumor diameter, and LMR were discovered to be common influences on the prognosis of patients with HCC and MVI when combined with the results of the intergroup comparison of MVI. After grouping, it was showed that patients with hepatocirrhosis, positive AFP (AFP ≥ 20 ng/mL), tumor diameter >50 mm, and LMR ≤3.4 had a significantly higher incidence of MVI than patients in other subgroups, and all four subgroups of MVI-positive patients had higher rates of early recurrence and mortality (p < 0.05).
MVI was found to be substantially linked with four subgroups of HCC patients with hepatocirrhosis, positive AFP, tumor diameter >50 mm, and LMR ≤3.4, and the prognosis of MVI-positive patients in all four subgroups tended to be worse.
探讨影响肝癌患者行肝切除术后发生微血管侵犯(MVI)及预后的因素,并探讨 MVI 对不同预后因素亚组预后的影响。
纳入 4 个治疗中心的 1633 例手术治疗的 HCC 患者的临床资料,其中 MVI 患者 754 例。采用 Cox 风险回归模型和 Mann-Whitney U 检验,明确影响预后和 MVI 的共同独立因素,然后检验各亚组的 MVI 发生率以及各亚组的 MVI 与预后的关系。
Cox 风险回归模型显示,MVI、Child-Pugh 分级、甲胎蛋白(AFP)、肝硬化、肿瘤直径、淋巴细胞单核细胞比值(LMR)和巴塞罗那临床肝癌(BCLC)分级是总生存(OS)的独立决定因素,MVI、AFP、肝硬化、肿瘤直径和 LMR 是无病生存(DFS)的影响因素。受试者工作特征(ROC)曲线显示,与其他预后因素相比,MVI 与患者预后最为密切相关。当结合 MVI 组间比较结果时,发现 AFP、肝硬化、肿瘤直径和 LMR 是影响 HCC 患者及 MVI 预后的共同因素。分组后发现,伴有肝硬化、AFP 阳性(AFP≥20ng/mL)、肿瘤直径>50mm 和 LMR≤3.4 的患者 MVI 发生率显著高于其他亚组,且 MVI 阳性的 4 个亚组患者均有较高的早期复发率和死亡率(p<0.05)。
MVI 与伴有肝硬化、AFP 阳性、肿瘤直径>50mm 和 LMR≤3.4 的 HCC 患者的 4 个亚组密切相关,且所有 4 个 MVI 阳性亚组患者的预后均较差。